Patents by Inventor Michinari FUJITA

Michinari FUJITA has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • AQUEOUS FORMULATION AND IN-SYRINGE AQUEOUS FORMULATION, AND ANTIBODY PROTEIN DEAGGREGATION AGENT AND ANTIBODY PROTEIN DEAGGREGATION METHOD
    Publication number: 20200093927
    Abstract: An aqueous formulation comprises ustekinumab, at least one selected from histidine and salts thereof, and water, wherein a content of the histidine and/or the salts thereof is 50 to 90 mM in terms of histidine.
    Type: Application
    Filed: March 30, 2018
    Publication date: March 26, 2020
    Applicants: MEIJI SEIKA PHARMA CO., LTD., Dong-A Socio Holdings Co., Ltd.
    Inventors: Arpansiree KAYA, Michinari FUJITA
  • STABLE AQUEOUS ADALIMUMAB FORMULATION
    Publication number: 20170189528
    Abstract: The present invention provides a stable aqueous adalimumab formulation by incorporating a histidine buffer solution and a phosphate buffer solution in combination. The incorporation of the histidine buffer solution and the phosphate buffer solution makes it possible to improve the stability of adalimumab.
    Type: Application
    Filed: June 4, 2015
    Publication date: July 6, 2017
    Applicants: MEIJI SEIKA PHARMA CO., LTD., DONG-A SOCIO HOLDINGS CO., LTD.
    Inventors: Arpansiree KAYA, Michinari FUJITA